UK markets open in 5 hours 28 minutes

Biomark Diagnostics Inc (BUX.CN)

Canadian Sec - Canadian Sec Real-time price. Currency in CAD
Add to watchlist
0.2200-0.0050 (-2.22%)
At close: 01:56PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
163.161
153.492
43.933
0
263.283
Operating expenses
Research development
704.293
545.841
497.773
118.432
42.347
Selling general and administrative
721.415
958.959
564.508
868.527
1,338
Total operating expenses
1,802
1,886
1,447
1,083
1,470
Operating income or loss
-1,638
-1,732
-1,403
-1,083
-1,207
Interest expense
96.95
110.232
49.683
4.138
2.392
Total other income/expenses net
-
-
-1.114
-7.467
-6.364
Income before tax
-1,538
-1,842
-1,454
-1,094
-1,215
Income from continuing operations
-1,538
-1,842
-1,454
-1,094
-1,215
Net income
-1,538
-1,842
-1,454
-1,094
-1,215
Net income available to common shareholders
-1,538
-1,842
-1,454
-1,094
-1,215
Basic EPS
-0.03
-0.02
-0.02
-0.02
-0.02
Diluted EPS
-0.03
-0.02
-0.02
-0.02
-0.02
Basic average shares
88,264
82,778
77,929
73,305
71,296
Diluted average shares
88,264
82,778
77,929
73,305
71,296